规模化与扩大应用:工程化 T 细胞治疗生产的进展与挑战
Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapies.
46.9分
★★★☆☆
站内排序·非疗效
DISEASE HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapies.
Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions.
MEMBER ACCOUNT
登录成功会直接打开下一页。